EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Heterojunction‐Engineered Mass Spectrometry Platform for Deciphering Serum Metabolic Fingerprints in Diagnosis of Respiratory Diseases

Junyu Chen, Chaoqi Wang, Xi Yu, Yuming Jiang, Yijiao Qu, Huihui Fu, Yuyin Bu, Xiaoyong Zhang, Zongxiu Nie

Advanced Science · 2026

DOI: 10.1002/advs.75597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Junyu Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Cl…. Hauptthemen laut MEDLINE: Metabolomics, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Mass Spectrometry. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Sciences Foundation of China, Jiangxi Provincial Natural Science Foundation, Jiangxi Provincial Health Commission Science and Technology Plan Project Youth Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory diseases, including bronchial asthma (BA), chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), and lung cancer (LCa), pose a major global health challenge due to overlapping symptoms that frequently delay accurate diagnosis. Although metabolomics‐based molecular phenotyping offers a promising path forward, its application in clinical treatment is limited by the use of conventional analytical techniques. Herein, MOF‐derived metal oxide/TiO 2 heterojunctions (including ZnTi, FeTi, CrTi, CuTi, and CoTi) are synthesized and evaluated as a nanomatrix for high‐throughput laser desorption/ionization mass spectrometry (LDI‐MS). CoTi is found to exhibit enhanced laser absorption, suppress charge recombination, improve photothermal desorption, and have a high tolerance to complex biofluids. This platform enables high‐quality serum metabolic fingerprints to be acquired from 776 clinical samples, accurately discriminates BA, COPD, ILD, and LCa from healthy controls, and precisely identifies the LCa stages when integrated with machine learning. AUC values of 0.950 and 0.956 are obtained for discovery and validation sets, respectively, across the five‐group classification by construction a 23‐metabolite diagnostic panel. This study not only introduces a rational heterojunction design strategy for LDI‐MS use but also establishes a robust, cost‐effective analytical platform bridging nanomaterials with clinical diagnostics, thereby providing a pathway toward metabolomics‐driven precision medicine for respiratory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationMass SpectrometryHumansBiomarkers

Stichwörter der Autor:innen

disease diagnosislaser desorption/ionization mass spectrometrymetabolic profilingmetal–organic framework hybridsrespiratory diseases

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Jiangxi Province Key Laboratory of Immunology and Inflammation, Jiangxi Provincial Clinical Research Center For Laboratory Medicine, Department of Clinical Laboratory, The Second Affiliated Hospital, Jiangxi Medical Col…
  • Beijing National Laboratory for Molecular Sciences, Key Laboratory of Analytical Chemistry For Living Biosystems, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
  • Department of Computational Biomedicine, Smidt Heart Institute, and Advanced Clinical Biosystems Research Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Department of Chemistry, Nanchang University, Nanchang, China.
  • State Key Laboratory of Tropic Ocean Engineering Materials and Materials Evaluation, School of Marine Science and Engineering, Hainan University, Haikou, China.

Förderung

  • National Natural Sciences Foundation of China
  • Jiangxi Provincial Natural Science Foundation
  • Jiangxi Provincial Health Commission Science and Technology Plan Project Youth Project
  • Incubation Program of the Second Affiliated Hospital of Nanchang University

Zitieren

APA

Chen, J., Wang, C., Yu, X., Jiang, Y., Qu, Y., Fu, H., Bu, Y., Zhang, X., & Nie, Z. (2026). Heterojunction‐Engineered Mass Spectrometry Platform for Deciphering Serum Metabolic Fingerprints in Diagnosis of Respiratory Diseases. Advanced Science. https://doi.org/10.1002/advs.75597

Vancouver

Chen J, Wang C, Yu X, Jiang Y, Qu Y, Fu H, et al. Heterojunction‐Engineered Mass Spectrometry Platform for Deciphering Serum Metabolic Fingerprints in Diagnosis of Respiratory Diseases. Advanced Science. 2026. doi:10.1002/advs.75597

BibTeX
@article{Chen2026,
  author = {Chen, Junyu and Wang, Chaoqi and Yu, Xi and Jiang, Yuming and Qu, Yijiao and Fu, Huihui and Bu, Yuyin and Zhang, Xiaoyong and Nie, Zongxiu},
  title = {Heterojunction‐Engineered Mass Spectrometry Platform for Deciphering Serum Metabolic Fingerprints in Diagnosis of Respiratory Diseases},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.75597}
}
Kostenlos starten →